✦ LIBER ✦

Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes

✍ Scribed by Kalbakis, K; Kouroussis, Ch; Kakolyris, S; Mavroudis, D; Souglakos, J; Agelaki, S; Vamvakas, L; Christodoulakis, M; Stylianou, K; Georgoulias, V

Book ID: 119981123
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 50 KB
Volume: 85
Category: Article
ISSN: 0007-0920
DOI: 10.1054/bjoc.2001.2001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage chemotherapy with high-dose leuc

Salvage chemotherapy with high-dose leucovorin (lv) and 5-fluorouracil (5-fu) 48-hour continuous infusion (ci) in combination with conventional doses of cyclophosphamide (c) in anthracycline/taxane refractory metastatic breast cancer (mbc) patients. A phase II study

✍ Kalbakis, K.; Agelaki, S.; Androulakis, N.; Kakolyris, S.; Kouroussis, C.; Mavro 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Oxaliplatin with high-dose leucovorin an

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

✍ A. de Gramont; J. Vignoud; C. Tournigand; C. Louvet; T. André; C. Varette; E. Ra 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 761 KB

A phase II study of alternating cycles o

A phase II study of alternating cycles of CPT-11 and high-dose 48 hour infusion 5-FU in combination with leucovorin (HD-5-FU/LV) in no selective patients with metastatic colorectal cancer (MCRC)

✍ G. Rosati; D. Bilancia; S. De Santis; A. Dinota; A. Rossi; L. Manzione 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Plasma and salivary pharmacokinetics of

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

✍ J.M Joulia; F Pinguet; M Ychou; J Duffour; C Astre; F Bressolle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A phase II study of irinotecan (CPT-11)

A phase II study of irinotecan (CPT-11) alternated with a weekly schedule of oxaliplatin (L-OHP), high-dose leucovorin (LV) and a 48-hour infusion 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer (MCRC)

✍ Rosati, G.; Tucci, A.; Rinaldi, A.; Colarusso, D.; Rossi, A.; Pizza, C.; Manzion 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Protracted continuous infusion of 5-fluo

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

✍ Alfredo Falcone; Giacomo Allegrini; Monica Lencioni; Elisabetta Pfanner; Isa Bru 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB